COR vs IR · P/E 21, rev $321.33B vs P/E 49, rev $7.24B
Cencora Inc. (COR) versus Ingersoll Rand Inc (IR) — a side-by-side from cached financials, not a winner call.
Cencora Inc. (COR) is a medical distribution company listed on NYSE.
Ingersoll Rand Inc (IR) is a specialty industrial machinery company listed on US.
Latest reported COR revenue for 2025-09-30 was $321.33B. Net income was $1.57B. Revenue was up 9.3% from 2024-09-30 to 2025-09-30. COR currently screens at market cap $53.91B and trailing P/E 21.2.
Latest reported IR revenue for 2024-12-31 was $7.24B. Net income was $846.3M. Revenue was up 5.2% from 2023-12-31 to 2024-12-31. IR currently screens at market cap $28.27B and trailing P/E 48.8.
COR currently screens at market cap $53.91B and trailing P/E 21.2. IR currently screens at market cap $28.27B and trailing P/E 48.8.
Not investment advice. Open the COR and IR stock pages for the full models.
Not investment advice.